Refine
Has Fulltext
- yes (10)
Is part of the Bibliography
- yes (10)
Document Type
- Journal article (10)
Language
- English (10)
Keywords
- obesity (4)
- liraglutide (3)
- Roux-en-Y gastric bypass surgery (2)
- gastric bypass (2)
- peptide tyrosine tyrosine (PYY) (2)
- Cushing’s syndrome (1)
- GLP-1 (1)
- NAFLD (1)
- NASH (1)
- PYY3-36 (1)
- RYGB (1)
- Roux-en-Y Gastric Bypass (1)
- Zucker fatty fa/fa rats (1)
- adjuvant treatment (1)
- adrenal cancer (1)
- adrenal tumours (1)
- adrenocortical cancer (1)
- adrenocortical carcinoma (ACC) (1)
- biomarker (1)
- blood pressure (1)
- branched-chain amino acids (1)
- efficacy (1)
- energy homeostasis (1)
- eosinophils (1)
- fatty liver (1)
- follow-up (1)
- glucose homeostasis (1)
- hypercortisolism (1)
- hypothalamic gene expression (1)
- insulin resistance (1)
- isturisa (1)
- leptin system (1)
- liquid chromatography–tandem mass spectrometry (LC–MS/MS) (1)
- medical therapy (1)
- melanoma (1)
- metabolomics (1)
- metyrapone (1)
- mitotane (1)
- osilodrostat (1)
- peptide tyrosine tyrosine 3-36 (PYY3-36) (1)
- peptide tyrosine tyrosine 3-36 (PYY\(_{3-36}\)) (1)
- phosphatidylcholines (1)
- radiotherapy (RT) (1)
- recurrence (1)
- recurrence free survival (1)
- rodent model (1)
- rygb (1)
- sphingolipids (1)
- steroid measurement (1)
- timing (1)
- treatment (1)
Institute
- Medizinische Klinik und Poliklinik I (10)
- Comprehensive Cancer Center Mainfranken (4)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (4)
- Institut für Molekulare Infektionsbiologie (2)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (1)
- Klinik und Poliklinik für Strahlentherapie (1)
- Medizinische Klinik und Poliklinik II (1)
- Pathologisches Institut (1)
Sonstige beteiligte Institutionen
Background: Eosinophils appear to contribute to the efficacy of immunotherapy and their frequency was suggested as a predictive biomarker. Whether this observation could be transferred to patients treated with targeted therapy remains unknown. Methods: Blood and serum samples of healthy controls and 216 patients with advanced melanoma were prospectively and retrospectively collected. Freshly isolated eosinophils were phenotypically characterized by flow cytometry and co-cultured in vitro with melanoma cells to assess cytotoxicity. Soluble serum markers and peripheral blood counts were used for correlative studies. Results: Eosinophil-mediated cytotoxicity towards melanoma cells, as well as phenotypic characteristics, were similar when comparing healthy donors and patients. However, high relative pre-treatment eosinophil counts were significantly associated with response to MAPKi (p = 0.013). Eosinophil-mediated cytotoxicity towards melanoma cells is dose-dependent and requires proximity of eosinophils and their target in vitro. Treatment with targeted therapy in the presence of eosinophils results in an additive tumoricidal effect. Additionally, melanoma cells affected eosinophil phenotype upon co-culture. Conclusion: High pre-treatment eosinophil counts in advanced melanoma patients were associated with a significantly improved response to MAPKi. Functionally, eosinophils show potent cytotoxicity towards melanoma cells, which can be reinforced by MAPKi. Further studies are needed to unravel the molecular mechanisms of our observations.